| Treatment options: Medical therapies |
|
Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992; 51 Suppl 1:59-67. |
|
Brady WM, Ogorek CP. Gastroesophageal reflux disease. The long and the short of therapeutic options. Postgraduate Medicine 1996; 100(5):76-80, 85-6, 89. |
|
Castell DO, Sigmund CJ, Patterson D, Lambert R, Hasner D, Clyde C, Zeldis JB. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. American Journal Of Gastroenterology 1998; 93(4):547-52. |
|
DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. American Journal Of Gastroenterology 1999; 94(6):1434-42. |
| El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A,
Sampliner RE. Proton pump imhibitors are associated with reduced
incidence of dysplasia in Barrett's esophagus. American Journal of
Gastroenterology 2004;99:1877-1883. |
|
Freston JW. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective. American Journal Of Gastroenterology 1997; 92(4 Suppl):51S-55S; discussion 55S-57S. |
|
Galmiche JP, Bruley des Varannes S, Endoluminal therapies for gastro-oesophageal reflux disease. Lancet, 2003. 361(9363): p. 1119-21. |
|
Galmiche JP, Fraitag B, Filoche B, Evreux M, Vitaux J, Zeitoun P, Fournet J, Soule JC. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Digestive Diseases And Sciences 1990; 35(5):649-55. |
|
Haringsma J, Siersema PD, and Kuipers EJ, Endoscopic treatment of gastro-oesophageal reflux disease: the new kid on the block. Scandinavian Journal of Gastroenterology. Supplement, 2003(239): p. 29-33. |
|
Heading RC, Baldi F, Holloway RH, Janssens J, Jian R, McCallum RW, Richter JE, Scarpignato C, Sontag SJ, Wienbeck M. Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996. European Journal Of Gastroenterology And Hepatology 1998; 10(1):87-93. |
| Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC.
Proton-pump inhibitor therapy and the development of dysplasia in
patients with Barrett's esophagus. MJA 2004;180:387-391. |
|
Hogan WJ and Shaker R, A critical review of endoscopic therapy for gastroesophageal reflux disease. The American Journal of Medicine, 2003. 115 Suppl 3A: p. 201S-10S. |
|
Koelz H. GERD: Nonoperative treatment: Inhibition of acid secretion in gastroesophageal reflux disease. In: Bchler MW FE, Klaiber Ch, Krhenbhl L, ed. Gastroesophageal Reflux Disease (GERD): Back to Surgery? Progress in Surgery, vol. 23, 1997; 71-82. Back to Surgery? Progress in Surgery, 1997 (vol 23). |
|
Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. American Journal Of Gastroenterology 1998; 93(5):763-7. |
|
Reilly JP. Safety profile of the proton-pump inhibitors. Am J Health-Syst Pharm 1999; 56 (Suppl 4): S11-17. |
|
Richter J. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complication. American Journal of Gastroenterology 2000; 98(2):368-373. |
|
Scott M, Gelhot AR. Gastroesophageal reflux disease: diagnosis and management. American Family Physician 1999; 59(5):1161-9, 1199. |
|
Sontag SJ, Schnell TG, Chejfec G, Kurucar C, Karpf J, Levine G. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Alimentary Pharmacology And Therapeutics 1997; 11(1):147-56. |
|
Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A, al e. A comparison of five maintenance therapies for reflux esophagitis [see comments]. New England Journal Of Medicine 1995; 333(17):1106-10. |
|
